November 12, 2019 / 9:44 PM / a month ago

GSK settles with insurers over 'egregious' drug manufacturing issues

GlaxoSmithKline PLC on Tuesday said it had reached an eve-of-trial settlement resolving claims by several insurers that it misled them into paying $2.7 billion for drugs made at a Puerto Rico plant in an “egregious” violation of federal manufacturing standards.

The settlement resolves a long-running lawsuit that was set to go to trial on Tuesday in federal court in Philadelphia revolving around manufacturing issues at a now-closed GSK plant in Cidra, Puerto Rico.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below